Events Archives - Page 102 of 128

2 minute read

Zymeworks Announces Abstract For Zanidatamab In Late-Line HER2-Positive Hormone-Receptor Positive Metastatic Breast Cancer At The San Antonio Breast Cancer Symposium

November 21, 10:07 AM

Zymeworks Inc. (NYSE:ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the publication of an abstract highlighting new clinical data for zanidatamab, a

ZYME

2 minute read

Cellectar Biosciences Announces Presentation Of Data On CLR 12120 Series Of Targeted Alpha-Emitting Therapies At The 13th Annual World ADC Conference

By Benzinga Newsdesk

November 21, 9:43 AM

Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the

CLRB

1 minute read

Bristol Myers Squibb Data At ASH 2022 Highlight Innovative Therapeutic Platforms Across A Range Of Blood Diseases

By Benzinga Newsdesk

November 21, 7:59 AM

New data from our multiple myeloma portfolio across targets and molecular approaches show significant progress toward our goal of transforming the treatment paradigm and improving outcomes for patients Multiple first

BMY

2 minute read

These 3 Mortgage REITs Have Yields Of Over 13% And Are Trading For Far Less Than They’re Worth

By Robert Kuczmarski

November 19, 4:58 PM

The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries. Mortgage REITs allow investors to join the real estate market without owning the physical property.

AJX

3 minute read

GM ‘Came Out Swinging’ At Its Investor Day: Automaker Raises 2022 Guidance, Lays Out Plans For EV Profitability In 2025

By Adam Eckert

November 17, 5:48 PM

At its Investor Day in New York City Thursday, General Motors Co (NYSE: GM) took on a more favorable outlook for the remainder of the year and raised longer-term expectations for

1 minute read

Events
News

Ticketmaster Says In A Tweet ‘Due To High Demands On Ticketing Systems Tomorrow’s Public On-Sale For Taylor Swift’s The Eras Tour Has Been Cancelled’

By Benzinga Newsdesk

November 17, 4:41 PM

https://twitter.com/Ticketmaster/status/1593333211769106433

LYV

2 minute read

Tiger Global Lost $16 Billion In 4 Months, But Held These 2 Dividend Payers

By Robert Kuczmarski

November 17, 12:59 PM

As of Nov. 14, hedge funds are required to release what trades they have made over the course of the third quarter.

2 minute read

3 Baltimore Blockchain Startups To Watch

By Philip Loyd

November 16, 6:22 PM

A blockchain is a decentralized peer-to-peer network utilizing distributed ledger technology (DLT). Blockchains are made up of an ever-expanding, trackable list of records, also known as blocks, which are linked together in a chain.

BTC

2 minute read

After A Tumultuous Q3, Warren Buffett Holds Onto 2 High Yielding Defensive Stocks

By Robert Kuczmarski

November 15, 5:41 PM

Warren Buffett, one of the most prolific Wall Street investors, is the fifth wealthiest in the world. The CEO and founder of Berkshire Hathaway Inc. (NYSE: BRK-A) boasts a net worth of more than $100 billion.

AAPL

2 minute read

Bill Gates Trims Berkshire Stake, Adds 2 New Positions – One Is A ‘Garbage’ Stock

By Robert Kuczmarski

November 15, 4:10 PM

Bill Gates has been known for buying up farmland as well as investing in disruptive companies to better combat climate change such as solid-state battery producer QuantumScape (NYSE:

BRK-B